POMALIDOMIDE

pomalidomide 2 mg capsule, 14

POMALIDOMIDE (13815D)

pomalidomide 2 mg capsule, 14
13815D
Body System:
Manner of administration:Oral
Public
S100 HSD Public
Authority Required

Restriction

Indication: Multiple myeloma
Treatment phase: Initial treatment with triple therapy (this drug, bortezomib and dexamethasone)

Restriction

Indication: Multiple myeloma
Treatment phase: Continuing treatment with triple therapy (this drug, bortezomib and dexamethasone)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 14 # of repeats: 2 DPMQ: $470.72 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Pomolide